Thursday, 25 May 2017

Vaccines News

  • Thai JE vaccine receives WHO nod

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Government of Pharmaceutical Organization, Thailand, recently announced that the attenuated Japanese encephalitis vaccine has received approval from the World Health Organiza...Read more

  • Malaria vaccine may be available by October

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The world's first malaria vaccine may be available by October, as the vaccine candidate (RTS,S/AS01) is the first to reach phase III clinical testing and is partially effective a...Read more

  • Vaxxas' painless vaccine delivery tech fetches BioSpectrum award

    Vaccines |  Influencers | By Amrita Tejasvi | 0 Comment

    Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland, came up with the idea of nanopatch technology in 2003. The te...Read more

  • Thai vaccine institute: Our nation needs robust vaccine alliances

    Vaccines |  Influencers | By Amrita Tejasvi | 0 Comment

    According to the WHO, Thailand has nearly 520,000 people (aged 5-to-49) living with HIV and AIDS and the country has the highest adult HIV prevalence in South East Asia region. Public healt...Read more

  • Chinese Ebola vaccine enters clinical trials

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: According to a Chinese news agency, the country's regulators have approved a domestically developed experimental Ebola vaccine for clinical trials. The deadly Ebola outbreak swep...Read more

  • Sanofi begins dengue immunization program in South Brazil

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Sanofi Pasteur, the vaccines division of Sanofi, has launched the first public dengue immunization program in Parana, a densely populated state in South of Brazil. "The world fi...Read more

  • Driving public health impact with vaccines: the past, present and way forward

    Vaccines |  Opinion | By BioSpectrum Bureau | 0 Comment

    Living in a time of unprecedented medical interventions, it is difficult to fully appreciate the contribution vaccines have made to human health. In fact, the widespread adoption of vaccine...Read more

  • China launches nationwide inspection of vaccines

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Ahead of a huge recent vaccine scandal racket revealing China's vaccine black market in March this year, Chinese health authorities have now appointed a special investigation tea...Read more

  • Fake vaccine scandal jolts Indonesia

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Indonesian Children may have to go through the pain of vaccination again as there is a recent police discovery suggesting the distribution of fake vaccines across the country. As...Read more

  • Protein Sciences, UNIGEN to source Flublok Influenza Vaccine from Japan

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Tokyo: North American pharmaceutical companies Protein Sciences Corporation and UMN Pharma Inc. have announced that Protein Sciences and UNIGEN Inc., a joint venture of UMN and IHI Corporat...Read more

  • Teva recalls amikacin sulfate injection

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP, 1 gram/4mL (250 mg/mL) vials due to the potential presence of particulate matt...Read more

  • ABIVAX to market typhoid, meningococcus vaccines in Asia

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, has collaborated with Finlay Institute, Hava...Read more

  • Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the next decade, rising from approximately $640 million in 2014 to over $2....Read more

  • Bill & Melinda Gates Foundation supports Takeda with $38 m to eradicate polio

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With th...Read more

  • Merck gets FDA nod for Bridion

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium) for the reversa...Read more

  • BioDiem gets hepatitis vaccine tech from Canberra univ

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to license a novel vaccine technology from the University of Canberra, expan...Read more

  • Infect mosquitoes with Wolbachia, stop diseases

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

  • Takeda close to releasing Norovirus vaccine

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies on a vaccine against norovirus, by the end of this year. Takeda's vacc...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls